As of Aug 26
| -0.06 / -0.70%|
The 7 analysts offering 12-month price forecasts for Achillion Pharmaceuticals Inc have a median target of 9.00, with a high estimate of 17.00 and a low estimate of 4.00. The median estimate represents a +5.39% increase from the last price of 8.54.
The current consensus among 7 polled investment analysts is to Buy stock in Achillion Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.